Cargando…
Lovastatin Inhibits Low Molecular Weight Hyaluronan Induced Chemokine Expression via LFA-1 and Decreases Bleomycin-Induced Pulmonary Fibrosis
BACKGROUND: Lovastatin has a unique ability to bind Leukocyte Function Antigen-1 (LFA-1), an integrin necessary for the full expression of inflammatory cytokines induced by the low molecular weight form of the extracellular matrix glycosaminoglycan hyaluronan (LMW HA). We hypothesized that lovastati...
Autores principales: | Hamblin, Mark J., Eberlein, Michael, Black, Katharine, Hallowell, Robert, Collins, Samuel, Chan-Li, Yee, Horton, Maureen R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Master Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199473/ https://www.ncbi.nlm.nih.gov/pubmed/25324695 |
Ejemplares similares
-
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis
por: Zhao, Hongyun, et al.
Publicado: (2014) -
Hyaluronan fragments induce IFNβ via a novel TLR4-TRIF-TBK1-IRF3-dependent pathway
por: Black, Katharine E, et al.
Publicado: (2013) -
Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression
por: Eberlein, Michael, et al.
Publicado: (2008) -
Lovastatin prevents bleomycin-induced DNA damage to HepG2 cells
por: Nasiri, Marjan, et al.
Publicado: (2016) -
Dynamic role of LMW-hyaluronan fragments and Toll-like receptors 2,4 in progression of bleomycin induced lung parenchymal injury to fibrosis
por: Pandey, Apoorva, et al.
Publicado: (2021)